Intel Seeks Cancellation Of Dopant Concentration Patent In New Petition

(January 30, 2023, 12:05 PM EST) -- ALEXANDRIA, Va. — In a Jan. 30 petition for inter partes review (IPR) filed with the Patent Trial and Appeal Board, Intel Corp. asserts five claims of a patent directed to grading dopant concentration in a semiconductor device would have been obvious to a person of ordinary skill in the art (POSITA) at the time of patenting....

Attached Documents

Related Sections